(E)-Ethyl 3-(pyridin-3-yl)acrylate, 97%, 5g

2,2'-Dihydroxy-1H,1'H-[2,2'-biindene]-1,1',3,3'(2H,2'H)-tetraone dihydrate, 97%, 25g

N-(quinoxalin-2-yl)hydroxylamine, 1g

2-(2-Bromophenyl)acetophenone, 97.0%, 250mg

Methyl 5-bromo-6-oxo-1,6-dihydropyridazine-3-carboxylate, 98%, 100mg

1-(tert-Butoxycarbonyl)-4-((5-fluoropyridin-2-yl)amino)piperidine-4-carboxylic acid, 97%, 5g

Molibdeno ICP soluzione standard, ROTI®Star, 10000 mg/l Mo, densità (D) 1,019 g/cm³

6-Phenylpyridine-2-carboxylic acid, 97.0%, 10g

(2S)-2-AMINO-2-(4-BROMOPHENYL)ETHAN-1-OL HCL, 95.0%, 1g

3-Amino-2-hydroxypyridine, 99.0%, 5g

[1-(2-hydroxyethyl)-3,5-dimethyl-1H-pyrazol-4-yl]acetic acid, 95.0%, 250mg

2',3,4,5-Tetrafluoro-4'-(trans-4-propylcyclohexyl)biphenyl>98.0%(GC)1g

3,4-Dihydroxybenzonitrile, 95.0%, 5g